Assignee
IMMVIRA CO LTD
CN·4 granted patents·5 pending applications·1 citations·filing 2016–2024
Top patents by PatentIndex Score
9 records- 0172US12304955B2Antibodies binding PD-1 and uses thereofIMMVIRA CO LTD·Filed 2024·Granted May 20, 2025·0 cites·8 claims
- 0264US10821140B2Construction of oncolytic herpes simplex viruses (oHSV) obligate vector and constructs for cancer therapyIMMVIRA CO LTD·Filed 2016·Granted Nov 3, 2020·1 cites·29 claims
- 0356US11439679B2Construction of oncolytic herpes simplex viruses (oHSV) obligate vector and constructs for cancer therapyIMMVIRA CO LTD·Filed 2020·Granted Sep 13, 2022·0 cites·12 claims
- 0453US2024024392A1Oncolytic herpes simplex type 1 viruses for treatment of brain tumorsIMMVIRA CO LTD·Filed 2021·Application pending·0 cites
- 0553US2023398144A1Exosomes containing mirnas targeting her2 synthesis and pharmaceutical compositionsIMMVIRA CO LTD·Filed 2021·Application pending·0 cites
- 0649US12037395B1Antibodies binding PD-1 and uses thereofIMMVIRA CO LTD·Filed 2019·Granted Jul 16, 2024·0 cites·10 claims
- 0746US2022347243A1Pharmaceutical compositions, kits and methods for treating tumorsIMMVIRA CO LTD·Filed 2019·Application pending·0 cites
- 0843US2021268049A1Methods and compositions for treatment of solid cancers and microbial infectionIMMVIRA CO LTD·Filed 2018·Application pending·0 cites
- 0943US2022296702A1Pharmaceutical compositions comprising oncolytic herpes simplex virus for systemic administrationIMMVIRA CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMVIRA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →